Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

All patients in both treatment arms completed the 20-week double-blind period of the study. In the 20-week double-blind period of the study, similar proportion of patients had adverse events (AEs) in ...

RESEARCH TRIANGLE PARK, N.C., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced that Norgine Pharmaceuticals ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.